TLSI Stock Analysis: Buy, Sell, or Hold?
TLSI - TriSalus Life Sciences, Inc. Common Stock
$4.54
-0.02 (-0.44%)
▼
5d:
+7.58%
30d:
+1.79%
90d:
+5.09%
BUY
HIGH Confidence
Analysis Updated: Jul 31, 2026 12:00 AM ET
Earnings: Aug 06, 2026
2d
Get Alerted When TLSI Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: TLSI shows strong fundamentals and good volume confirmation. Solid entry point despite slightly high pricing.
✅ BUY SIGNAL: TLSI shows strong fundamentals and good volume confirmation. Solid entry point despite slightly high pricing.
In-depth Analysis How we analyze
Valuation Analysis: TLSI is currently trading at $4.54, which is considered slightly high relative to its 30-day fair value range of $4.07 to $4.55.
Technical Outlook: Technically, TLSI is showing sideways momentum. The price is approaching resistance at $4.59. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: TLSI has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $9.00 (+98.2%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, TLSI is showing sideways momentum. The price is approaching resistance at $4.59. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: TLSI has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $9.00 (+98.2%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
SLIGHTLY HIGH
Historical Trading Range
$4.07 -
$4.55
Company Quality Score
55/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
78.9%
All Signals
- BULLISH: Strong technical setup (75/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 98.2% below Wall St target ($9.00)
Trading Range Analysis
30-Day Trading Range
$4.07 -
$4.55
Current vs Trading Range
SLIGHTLY HIGH
Support & Resistance Levels
Support Level
$4.00
Resistance Level
$4.59
Current Trend
Sideways
Technical data as of
Jul 31, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-31.86
Wall Street Target
$9.00
(+98.2%)
Revenue Growth (YoY)
-2.9%
Profit Margin
-60.9%
Share & Embed Analysis
Last updated: August 03, 2026 2:14 AM ET
Data refreshes hourly during market hours. Next update: 3:14 AM
Data refreshes hourly during market hours. Next update: 3:14 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is TLSI showing a specific setup today?
Insider Activity (6 Months)
0
Buys
11
Sells
Net
INSIDERS SELLING
Recent Transactions
Mary T Szela
SELL
15944 shares
2026-03-17
Bryan F Cox
SELL
579 shares
2026-03-16
Jodi Devlin
SELL
273 shares
2026-03-16
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BSX
Boston Scientific Corp |
STRONG BUY
34 analysts |
$64 | 55 HOLD |
|
DXCM
DexCom Inc |
STRONG BUY
27 analysts |
$93 | 49 HOLD |
|
SYK
Stryker Corporation |
BUY
32 analysts |
$384 | 51 HOLD |
|
ABT
Abbott Laboratories |
STRONG BUY
27 analysts |
$118 | 52 HOLD |
|
EW
Edwards Lifesciences Corp |
HOLD
32 analysts |
$101 | 52 HOLD |
